Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk [Seeking Alpha]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Seeking Alpha
SNY strengthens its adult vaccine portfolio with HEPLISAV-B, a commercial hepatitis B vaccine, and gains a long-term option on DVAX's shingles candidate. The acquisition is low-risk, funded from SNY's cash reserves, with no impact on 2025 guidance; SNY maintains a Buy rating, DVAX a Hold. DVAX shareholders receive a ~39% premium, but upside from pipeline assets like Z 1018 now shifts to SNY; no meaningful arbitrage remains. aerogondo/iStock via Getty Images Overview Dynavax ( DVAX ) is joining forces with Sanofi ( SNY ) this Festivus season! Revealed on Christmas Eve, Sanofi will acquire Dynavax for $15.50 per share in cash via a tender offer. This values Dynavax at ~$2.2 billion This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger [Yahoo! Finance]Yahoo! Finance
- Assessing Dynavax After a 42% Surge and Strong HEPLISAV B Growth in 2025 [Yahoo! Finance]Yahoo! Finance
- Asian shares are mixed after US stocks drift to more records [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Why Dynavax Stock Soared Today [Yahoo! Finance]Yahoo! Finance
- How major US stock indexes fared Wednesday, 12/24/2025 [Yahoo! Finance Canada]Yahoo! Finance Canada
DVAX
Earnings
- 11/5/25 - Beat
DVAX
Sec Filings
- 11/5/25 - Form 10-Q
- 11/5/25 - Form 8-K
- 10/16/25 - Form 8-K
- DVAX's page on the SEC website